Insight

Anand Patel: Myeloid neoplasms after MTX have features more similar to de-novo

Photo from

Jul 24, 2024, 00:57

Anand Patel: Myeloid neoplasms after MTX have features more similar to de-novo

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a post on X/Twitter:

“We often discuss if myeloid neoplasms after MTX therapy have high-risk features/cytogenetics – this report found myeloid neoplasms after MTX have features more similar to de-novo disease than t-MN.”

Source: Anand Patel/X

Anand Patel

Authors: Mihir D. Wechalekar, Lin-Pierre Zhao, Monika M. Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S. Scott, Anna Brown, Christopher C. Hahn, Karin Kassahn, Dariusz Ladon, David T. Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V. Shah, Chung H. Kok and Devendra K. Hiwase

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features

Anand Patel Anna Brown cancer Christopher C. Hahn Chung H. Kok Daniel Thomas Dariusz Ladon David T. Yeung Devendra K. Hiwase Hamish S. Scott Joule Li Karin Kassahn Kevin Hung Lih En Hong Lin-Pierre Zhao Lionel Ades Mihir D. Wechalekar Mithun V Shah Monika M. Kutyna Mrinal Patnaik MTX myeloid neoplasms OncoDaily Oncology Susanna Proudman University of Chicago

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage